Oxfordshire
United Kingdom
University of Oxford - Respiratory Medicine Unit
COVID-19; Coronavirus; SAR-CoV-2; Azithromycin; Macrolide; Randomised controlled trial; Respiratory failure; Mortality; Trial
Asthma, bacteria, microbiome, sputum, cytokine
hypoxia, HIF, SARS-CoV-2, Roxadustat